Vivos Inc. Files Early Feasibility IDE Application with FDA for Radiogel™
20 sept. 2021 09h30 HE
|
Vivos Inc.
Richland WA, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. is pleased to announce that it has submitted the IDE, Investigational Device Exemption for The Early Feasibility...
Vivos Inc. Provides 2019 Recap and Outlines 2020 Objectives
13 janv. 2020 07h30 HE
|
Vivos Inc.
Richland WA, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), provides 2019 recap and outlines future objectives. Vivos’ CEO, Dr. Mike Korenko stated, “as we begin 2020, I think it is...
Vivos Inc. Treats Additional Patients at its Pilot Clinic
03 déc. 2019 07h00 HE
|
Vivos Inc.
Richland WA, Dec. 03, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) today announced that two dogs with different cancer types were treated using Vivos Inc.’s Isopet® therapy on November 27 at...
Vivos Inc Signs a Standstill Agreement with Debt Holders Designed to Halt the Toxic Selling and Eliminate the Secured Toxic Debt
24 sept. 2018 07h00 HE
|
Vivos Inc.
Richland WA , Sept. 24, 2018 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) Vivos Inc is pleased to announce that all the debtholders of Vivos’ secured convertible debt have agreed to a ten...
Vivos Inc Successfully Treats Canine Sarcoma with IsoPet™ (RadioGel™)
31 mai 2018 06h00 HE
|
Vivos Inc.
Richland, WA, May 31, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) successfully treated canine soft tissue sarcoma with its proprietary IsoPet™ (RadioGel™), a hydrogel liquid containing tiny...
Vivos Demonstrates that IsoPet™ (RadioGel™) is effective in killing cancer in cats
01 mai 2018 09h00 HE
|
Vivos Inc.
Richland, WA, May 01, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) announced today the results from the therapy for feline sarcoma. Five cats were treated at Washington...
Vivos Adds Commercial Expertise to its Veterinary Medicine Advisory Board
20 mars 2018 09h30 HE
|
Vivos Inc.
Richland, WA, March 20, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) announced today that it added a new member on the Veterinary Medicine Advisory Board. Tariq Shah BSc. DipMS is the...
Vivos Receives FDA Confirmation of RadioGel Device Classification for Animal Skin Cancer Therapy
30 janv. 2018 09h00 HE
|
Vivos Inc.
Richland, WA, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) announced today that it has been notified by the FDA that RadioGel™ is classified as a device for animal therapy. ...
Advanced Medical Isotope Corporation (ADMD) Refines Strategy to Accelerate Penetration of Veterinary Market
17 nov. 2017 06h45 HE
|
Advanced Medical Isotope Corporation
RICHLAND, WA, Nov. 17, 2017 (GLOBE NEWSWIRE) -- Advanced Medical Isotope Corporation (OTC PINK: ADMD), a late-stage radiation oncology-focused medical device company, is initially focusing its...